Bd Onclarity
Payments companies reported to CMS as associated with Bd Onclarity. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Bd Onclarity, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Bd Onclarity
These are the largest totals companies reported as associated with Bd Onclarity. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Phillip Stephenson | Ogden, UT | Cytopathology | $956.20 |
| Michael Icardi | Iowa City, IA | Anatomic Pathology & Clinical Pathology | $637.81 |
| Kylee Johnson | Idaho Falls, ID | Nurse Practitioner | $443.29 |
| Miguel Albert | Miami, FL | Obstetrics & Gynecology | $262.76 |
| Mikayla Andrea | Phoenix, AZ | Primary Care | $259.87 |
| Kristina Calligan | Phoenix, AZ | Family | $259.87 |
| Jordan Winchester | Chandler, AZ | Family | $259.86 |
| Tessa Farley | Phoenix, AZ | Nurse Practitioner | $259.86 |
| Heather Zechman | Phoenix, AZ | Obstetrics & Gynecology | $259.86 |
| Esosa Nwambuonwo | Phoenix, AZ | Obstetrics & Gynecology (Nurse Practitioner) | $259.86 |
Prescribed Bd Onclarity?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.